Medical Devices & Technology

Toronto – November 10, 2026 -- Profound Medical Corp. (NASDAQ: PROF; TSX: PRN) will put three senior executives in front of investors at the Stifel 2026 Healthcare Conference in New York City, with President Richard Fabian presenting on Thursday, November 12, 2026, at 8:40 a.m. Eastern Time.

Profound will broadcast Fabian's November 12 session live and archive it online

The commercial-stage interventional MRI (iMRI) company will make the webcast available on its website. Chief Executive Officer and Chairman Arun Menawat and Chief Financial Officer Matthew Sobczyk will join Fabian for one-on-one investor meetings during the conference.

Investors seeking a one-on-one slot must go through their Stifel representative.

VANCOUVER – November 10, 2026 -- WAT Medical Enterprise Ltd. is renewing its US$1 donation to The American Legion for every HeadaTerm 2 device sold, marking the eighth consecutive year of the program and widening its veteran-focused support to device donations, purchase discounts and clinical research.

WAT Medical ties veteran giving directly to HeadaTerm 2 unit sales

The per-unit donation to The American Legion links the company's charitable spending to sales volume of HeadaTerm 2, its wearable device. The product is FDA-cleared for the prevention of episodic migraine in adults and is marketed as a portable, drug-free option.

PRINCETON, N.J. – November 10, 2026 -- CytoSorbents Corporation (NASDAQ: CTSO) will send CEO Dr. Phillip Chan and CFO Peter Mariani to the Jefferies Global Healthcare Conference in London on November 16-18, 2026, for one-on-one investor meetings.

Investors can book CytoSorbents management meetings through the Jefferies conference website

Meetings can be scheduled through the conference website, or through the company's investor relations team for sessions outside the event. The conference is in its 17th year and is Jefferies' flagship European healthcare investment gathering. It draws C-suite executives, public, private equity and venture capital investors, and strategists across biotech, pharmaceuticals, medical technology, healthcare services, digital health and healthcare IT.

Munich – November 09, 2026 -- No video carries a verified subtitle track at 36 of 50 medical technology companies examined, or 72%, according to an audit by purple.audio, the transcription platform of Spotwatch GmbH.

Only 34 of 578 product and training videos carry checked subtitles

Across 578 videos on products, applications and training, 34 (5.9%) have a verified subtitle track. Another 155 run on unverified machine-generated text, and 389 have no subtitle track at all.

None of the 885 videos reviewed has a detectable audio description track.

Company-run players omit subtitles in 325 of 346 spoken-word videos

In companies' own video players, the subtitle track is missing from 325 of 346 videos containing speech. In 283 of 497 cases, the page code lacked even the control for switching subtitles on.

SAN FRANCISCO – November 06, 2026 -- Avive Solutions, Inc. will deploy 25 Avive Connect AEDs as First Aid Sponsor of the 2026 Good Life Halfsy, Nebraska's largest half marathon, where 9,500 registered runners and more than 20,000 spectators are expected.

The 13th annual event in Lincoln, Nebraska, is projected to generate a $3.4 million economic impact for the region. Producer Pink Gorilla Events has generated more than $1.1 million in donations to local charities and nonprofits through its races.

Medical volunteers will carry Avive AEDs along the 13.1-mile course

The event's medical volunteers will carry the devices, putting them in the hands of trained responders along the route. A Good Life Halfsy co-race director said the added units are meant to strengthen race-day emergency preparedness for runners, spectators and volunteers.

PARSIPPANY, N.J. – November 06, 2026 -- Onkos Surgical has received its fourth FDA 510(k) clearance for NanoCept Antibacterial Technology since the coating won De Novo authorization in April 2024, extending it to more titanium components of the ELEOS Limb Salvage System.

Clearance covers femurs, tibial baseplates and stems

The new clearance adds proximal femurs, tibial baseplates and augments, and cemented bowed segmental stems to the NanoCept portfolio. It also permits broader NanoCept coverage on titanium components that were previously cleared.

The decision follows an earlier clearance this year that applied NanoCept to titanium implants.

Fullerton – November 06, 2026 -- Esperto Medical, Inc., a critical care and remote patient monitoring startup, has received a grant from the Translational Research Institute for Space Health (TRISH) to adapt its Resonance Sonomanometry (RSM) technology for microgravity and other extreme environments.

RSM measures arterial pressure with sound waves and needs no calibration

RSM uses sound waves at different frequencies to measure blood pressure directly within arteries. Esperto says this avoids the variability of other approaches. The system requires no calibration, which simplifies setup and use.

Platform targets three autonomous data streams for astronaut monitoring

Esperto's RSM technology is designed to assess the following autonomously:

HANGZHOU – November 06, 2026 -- Zylox-Tonbridge Medical Technology (HKEX: 2190) and GL Capital will jointly invest about HK$1.482 billion in LifeTech Scientific (HKEX: 1302) for roughly 16.7% of its enlarged share capital. Zylox-Tonbridge also intends to pursue a potential merger with LifeTech.

Lighthouse Two vehicle becomes LifeTech's largest shareholder

The investment runs through GL Lighthouse Two Investment Limited, which will subscribe for newly issued LifeTech shares. On completion, Lighthouse Two becomes LifeTech's largest single shareholder. Zylox-Tonbridge holds 60% of the vehicle through an investment of about HK$889 million.

Both investors may acquire additional LifeTech shares to support closer collaboration.

Addison, Texas – November 06, 2026 -- FX Shoulder Solutions has received FDA 510(k) clearance for Easytech Reversed, which the company describes as the first and only stemless reverse shoulder arthroplasty system cleared in the United States. The clearance follows nearly eight years of US clinical investigation.

Seven-site IDE study enrolled 90 patients

FX started the US Investigational Device Exemption (IDE) study in 2018. The multicenter investigation ran across seven sites and covered 90 patients. Follow-up was completed in 2023 and supports the regulatory submission, according to the company. FX also cites more than a decade of international clinical experience with its Easytech technology.

Tampa – November 06, 2026 -- Medicare will pay a national non-facility (office) rate of approximately $19,441 for CPT code 27279 starting January 1, 2027, according to PainTEQ's reading of the CMS Calendar Year 2027 Physician Fee Schedule Final Rule (CMS-1848-F). The code covers percutaneous or minimally invasive sacroiliac (SI) joint arthrodesis using devices with intrinsic fixation that pierce the cortices. It had no office rate before that date.

CMS finalizes practice expense inputs that create the first office rate for 27279

Under the 2026 Physician Fee Schedule, code 27279 carried a facility payment rate only. For 2027, CMS finalized the RUC-recommended practice expense inputs, which produce the new office rate. The $19,441 figure is before geographic adjustment, sequestration and patient cost sharing, and actual payment varies by locality.